Immunogenicity risk assessment of novel modalities using new approach methodologies

Vijaya L. Simhadri, Sharon Vijayanand, Vibha Jawa, Zuben E. Sauna
Nature Reviews Drug Discovery · Springer Nature · 2026-11-13 · DOI: 10.1038/s41573-026-01562-9

Abstract

Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/s41573-026-01562-9 Novel therapeutic modalities such as cell therapies and gene editors could potentially treat many diseases, but their clinical progression is limited by unwanted immune responses. This Perspective proposes how ‘new approach methodologies’ such as computational tools and organoids can be applied to assess the immunogenicity of novel modalities, given the limited translational value of immunogenicity data from traditional animal models.

Read at publisher →

Similar articles